Home Page
Where things stand with the TRIPS waiver
The World Trade Organization is considering continuing to waive certain intellectual property rights on COVID-19 diagnostics and therapeutics, following a recent decision to do the same for vaccines.
Read MoreExpanding COVID IP waiver would harm small, medium enterprises, CSBA says
Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology.
Read More2022 NCBIO Year in Review
In this past year, we emerged from the isolation of COVID-19 thanks in no small part to the heroic work of the life sciences industry in developing vaccines, rapid tests and new treatments that have made the pandemic much more manageable. In spite of this success, we have faced tremendous pressure at the federal level with threats to intellectual property, the lifeblood of the industry, and a push to insert price controls with potential repercussions on innovation.
Read MoreBurr shares insights from 28-year Congressional career
Sen. Richard Burr reflected on his 28-year career in Congress and discussed FDA reform, the nation’s response to future pandemics and the pitfalls of the nation’s regulatory system at the 2022 NCBIO Annual Dinner held Monday, Oct. 10, at the NC Biotechnology Center.
Read MoreWorkforce and talent development topics of discussion at September BMF meeting
At their quarterly meeting held Wednesday, Sept. 14, members of the NCBIO Biomanufacturers Forum learned about efforts and options for bolstering workforce and talent development in North Carolina. Members also received an update on the $25 million Build Back Better awarded to expand, connect and promote training and career opportunities in North Carolina.
Read MoreAt Legislative Luncheon, legislators encourage NCBIO members to make industry needs known
The co-chairs of the NC Life Sciences Caucus talked about workforce issues, transportation, infrastructure and economic development and asked NCBIO members to communicate the wants and needs of the life sciences industry at the NCBIO Legislative Luncheon and Forum held Wednesday, Aug. 31, at the NC Biotechnology Center.
Read MoreSecond class of Sam Taylor life sciences scholarship recipients named
The second class of recipients of the Samuel M. Taylor Memorial Life Sciences Scholarship in the NC Community Colleges Foundation have been named. This year, five scholarships have been awarded.
Read MorePart D drug price “negotiation” comes at cost of jobs, investment, cures
Congress passed the Inflation Reduction Act on Aug. 12. Included in the law is a provision that gives Medicare Part D the ability to “negotiate” the price of medicines for the first time. Negotiate is in quotation marks because lawmakers are being ironic; no one can legitimately call the new price-setting policy a negotiation.
Read MoreLab Space Forum discusses tight supply, innovative solutions to lab space shortage
Strategies for meeting the booming demand for lab space in the Triangle and across North Carolina were shared and discussed by panelists from Azzur Group, Lee & Associates, Longfellow Real Estate Partners and Lincoln Harris at the NCBIO Lab Space Forum and Luncheon held Thursday, July 14, at the NC Biotechnology Center.
Read MoreNorth Carolina unified in attracting new ARPA-H headquarters to the state
Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.
Read More